Current Issues in Anaemia Management and IV Iron Therapy in CKD
|
CKD-MBD (Chronic Kidney Disease – Mineral Bone Disorder) – 40 years on, how far have we come?
This will be a highly informative Satellite to update the nephrology team on how to manage this important and challenging condition. |
'Theory into practice: bringing stability to Hb cycling'
|
| Evidence into Practice:Guideline Implementation |
| Dr Paul Stevens, Consultant Nephrologist - East Kent Hospitals University NHS Foundation Trust
|
| 'Going Upstream' The Implications and Opportunities of Early Detection |
| Dr Donal O' Donoghue, National Clinical Director - National Clinical Director for Kidney Care, Salford Royal NHS Foundation Trust
|
| Creative Iron Management |
| Karen Jenkins, Consultant Nurse, Renal Services -
|
| IV Iron in CKD: Current Controversies |
| Professor Kam Kalantar-Zadeh -
|
| Is Normalising Haemoglobin in Patients with CKD Harmful, and if so, why? |
| Dr Tim Littlewood, Consultant Haemotologist -
|
| Evolution of IV Iron Compounds over the Last Century |
| Dr Iain Macdougall, Consultant Nephrologist -
|
|
|
|
| - Sessions are included for the entire multi-disciplinary team.
Interactive panel discussions and keypad participation.
|
| Bruce Hendry,Kings College, London |
| Philip Kalra,Salford Royal NHS Foundation Trust |
| Nick Pritchard,Addenbrookes Hospital,Cambridge |
|
| Foreword - erythropoiesis-stimulating agent (ESA) management:clinical success and challenges |
| Donal O' Donoghue - National Clinical Director
|
| Aspirational Range and Action Thresholds for Hb |
| Gilbert Deray - Professor of Nephrology, Paris
|
| Hb cycling: fact or fiction? |
| Steven Fishbane - Professor of Medicine, New York
|
| Bringing Stability to Hb Cycling |
| Francesco Locatelli - Professor and Director of Department of Nephrology, Alessandro Manzoni Hospital, Lecco
|
|